Home/Filings/4/0001209191-17-047949
4//SEC Filing

HAMPTON GEORGE P 4

Accession 0001209191-17-047949

CIK 0001492426other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 5:53 PM ET

Size

9.0 KB

Accession

0001209191-17-047949

Insider Transaction Report

Form 4
Period: 2017-08-05
HAMPTON GEORGE P
See remarks
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2017-08-05+18,75044,617 total
  • Tax Payment

    Ordinary Shares

    2017-08-05$12.70/sh7,866$99,89836,751 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-08-0518,75037,500 total
    Ordinary Shares (18,750 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
  • [F2]Includes 1,141 ordinary shares of the Issuer acquired by the reporting person on June 1, 2017 pursuant to an employee stock purchase program.
  • [F3]On August 5, 2015, the reporting person was granted an aggregate of 75,000 restricted stock units. The restricted stock units vest in four equal annual installments beginning on August 5, 2016.

Issuer

Horizon Pharma plc

CIK 0001492426

Entity typeother

Related Parties

1
  • filerCIK 0001650147

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:53 PM ET
Size
9.0 KB